EichorEICHOR
Location: Saint Paul Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Saint Paul

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Alfasigma S.p.A. · NCT06865417Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Hospices Civils de Lyon · NCT05444712A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Regeneron Pharmaceuticals · NCT06091865PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
Phase 3 · Assistance Publique - Hôpitaux de Paris · NCT05387954Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma
Phase 3 · Federation Francophone de Cancerologie Digestive · NCT07270991A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Phase 3 · Pfizer · NCT07029828Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
Phase N/A · Acute Leukemia French Association · NCT04777916A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · Bristol-Myers Squibb · NCT05489705Skipping Hormone Therapy in Low-Risk Early Breast Cancer
Phase 2 · UNICANCER · NCT07661927COsegregation of VARiants in Panel of Genes
NA · Institut Curie · NCT01689584Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
Phase 2/Phase 3 · ARCAGY/ GINECO GROUP · NCT03651206CHLORDECONE EXPOSURE AND PROSTATE CANCER IN THE FRENCH REGION OF MARTINIIQUE
Phase N/A · Institut National de la Santé Et de la Recherche Médicale, F · NCT06773806A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · Ipsen · NCT06016842Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders
Phase 3 · Centre Hospitalier Universitaire de Saint Etienne · NCT05136976REal World Data in LYmphoma and Survival in Adults
Phase N/A · Hospices Civils de Lyon · NCT03869619Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Phase 1/Phase 2 · Stemline Therapeutics, Inc. · NCT05386108RA-PRO PRAGMATIC TRIAL
Phase 3 · University of Alabama at Birmingham · NCT04692493Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Merck Sharp & Dohme LLC · NCT03486873A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
NA · UNICANCER · NCT05639413Initial Standardized Global Review in Axial Spondyloarthritis
NA · Association de Recherche Clinique en Rhumatologie · NCT07141017A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif
Phase 2/Phase 3 · Pfizer · NCT06989437Observatory of the Lille Paediatric Allergy Unit
Phase N/A · Lille Catholic University · NCT06634992Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR
Phase 3 · Tourcoing Hospital · NCT04672525A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Hoffmann-La Roche · NCT05878769Registry for Patients With X-Linked Hypophosphatemia
Phase N/A · Kyowa Kirin Pharmaceutical Development Ltd · NCT03193476Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
Phase 3 · Centre Francois Baclesse · NCT04290663First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
Phase 2 · GERCOR - Multidisciplinary Oncology Cooperative Group · NCT06253611The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage Hepato
Phase 3 · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT04803994A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leuke
Phase 3 · Janssen Research & Development, LLC · NCT06852222Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases
Phase 3 · Institut Cancerologie de l'Ouest · NCT06471465
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.